Molecular prognostic factors for breast carcinoma


Book Section

© 2018 Elsevier Inc. All rights reserved. Molecular genomic testing provides clinicians with prognostic and predictive information that can help individualize treatment, decrease the risk of over-or under-treatment, and, accordingly, improve outcomes. In this chapter, we describe several of the genomic tests that are currently available for clinical use in the management of breast cancer. We also discuss ongoing research related to validating and expanding their utility in different patient populations and explain why it is important for clinicians to incorporate these tools into their practice.

Full Text

Duke Authors

Cited Authors

  • Fayanju, OM; Lucci, A

Published Date

  • August 24, 2017

Book Title

  • The Breast: Comprehensive Management of Benign and Malignant Diseases

Start / End Page

  • 258 - 263.e2

International Standard Book Number 13 (ISBN-13)

  • 9780323359559

Digital Object Identifier (DOI)

  • 10.1016/B978-0-323-35955-9.00019-2

Citation Source

  • Scopus